Quick Answer
OCULAR THERAPEUTIX, INC reported Stockholders Equity of $654.31 million for the year ending 2025.
- OCULAR THERAPEUTIX, INC showed an increase of +107.5% in Stockholders Equity from 2024 to 2025.
- This data is from OCULAR THERAPEUTIX, INC's annual report (Form 10-K), filed with the SEC on February 5, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2014: -$69.44 million | Q3 2014: $65.60 million | Q1 2015: $52.07 million | Q2 2015: $109.11 million | Q3 2015: $98.81 million | Q1 2016: $80.17 million | Q2 2016: $70.45 million | Q3 2016: $62.29 million | Q1 2017: $63.91 million | Q2 2017: $48.03 million | Q3 2017: $35.92 million | Q1 2018: $49.18 million | Q2 2018: $45.73 million | Q3 2018: $45.52 million | Q1 2019: $25.65 million | Q2 2019: $8.26 million | Q3 2019: $11.30 million | Q1 2020: -$10.66 million | Q2 2020: $5.34 million | Q3 2020: -$4.13 million | Q1 2021: $83.41 million | Q2 2021: $80.25 million | Q3 2021: $87.34 million | Q1 2022: $79.80 million | Q2 2022: $65.80 million | Q3 2022: $46.23 million | Q1 2023: $9.71 million | Q2 2023: $3.09 million | Q3 2023: $7.85 million | Q1 2024: $407.98 million | Q2 2024: $377.70 million | Q3 2024: $352.02 million | Q1 2025: $265.93 million | Q2 2025: $305.92 million | Q3 2025: $258.23 million.
- Over the full 15 years of available data (2011 to 2025), OCULAR THERAPEUTIX, INC's Stockholders Equity has grown by 2,099.2%.
- Historical annual values: Fiscal year 2025: $654.31 million | Fiscal year 2024: $315.34 million | Fiscal year 2023: $91.13 million | Fiscal year 2022: $35.38 million | Fiscal year 2021: $88.00 million | Fiscal year 2020: $76.10 million | Fiscal year 2019: -$3.63 million | Fiscal year 2018: $35.88 million | Fiscal year 2017: $26.15 million | Fiscal year 2016: $52.01 million | Fiscal year 2015: $89.59 million | Fiscal year 2014: $58.70 million | Fiscal year 2013: -$59.47 million | Fiscal year 2012: -$46.61 million | Fiscal year 2011: -$32.73 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: